Comment on: Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission: Reply

被引：0
|
作者：
Merkt, Wolfgang [1 ,2 ]
Roehrich, Manuel [3 ,4 ]
机构：
[1] Univ Hosp Heidelberg, Dept Hematol Oncol & Rheumatol, Internal Med 5, Heidelberg, Germany
[2] Univ Hosp Dusseldorf, Dept Rheumatol, Moorenstr 5, D-40225 Dusseldorf, Germany
[3] Heidelberg Univ Hosp, Dept Nucl Med, Heidelberg, Germany
[4] Mainz Univ Hosp, Dept Nucl Med, Mainz, Germany
来源：
RHEUMATOLOGY | 2024年
关键词：
D O I：
10.1093/rheumatology/keae582
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 43 条
  • [1] Comment on: Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission
    Bolek, Ertugrul Cagri
    Karadeniz, Hazan
    Tufan, Abdurrahman
    RHEUMATOLOGY, 2024,
  • [2] Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission
    Roehrich, Manuel
    Rosales, Juan J.
    Hoppner, Jorge
    Kvacskay, Peter
    Blank, Norbert
    Loi, Lisa
    Paech, Daniel
    Schreckenberger, Mathias
    Giesel, Frederik
    Kauczor, Hans Ulrich
    Lorenz, Hanns Martin
    Haberkorn, Uwe
    Merkt, Wolfgang
    RHEUMATOLOGY, 2024, 63 (09) : 2473 - 2483
  • [3] Cardiac fibroblast activation in Fabry disease on 18F-fibroblast activation protein inhibitor positron emission tomography/computed tomography imaging
    Wang, Yi-Lu
    Wang, Li
    Dong, Zhixiang
    Yang, Min-Fu
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2022, 6 (11)
  • [4] Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease
    Mpanya, Dineo
    Sathekge, Mike
    Klug, Eric
    Damelin, Jenna
    More, Stuart
    Hadebe, Bawinile
    Vorster, Mariza
    Tsabedze, Nqoba
    FRONTIERS IN NUCLEAR MEDICINE, 2023, 3
  • [5] Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)
    Yuriko Mori
    Emil Novruzov
    Dominik Schmitt
    Jens Cardinale
    Tadashi Watabe
    Peter L. Choyke
    Abass Alavi
    Uwe Haberkorn
    Frederik L. Giesel
    npj Imaging, 2 (1):
  • [6] Fibroblast activation protein inhibitor positron emission tomography imaging in muscles of patients with idiopathic inflammatory myopathy
    Zhang, Yuying
    Zhang, Bing
    Niu, Yuanyuan
    Long, Yali
    He, Qiao
    Luo, Guangxi
    Xu, Hanshi
    Zhang, Xiangsong
    Zhan, Zhongping
    Chen, Dongying
    RHEUMATOLOGY, 2024,
  • [7] The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review
    Albano, Domenico
    Rizzo, Alessio
    Slart, Riemer H. J. A.
    Hess, Soren
    Noriega-Alvarez, Edel
    Wakfie-Corieh, Cristina Gamila
    Leccisotti, Lucia
    Glaudemans, Andor W. J. M.
    Gheysens, Olivier
    Treglia, Giorgio
    PHARMACEUTICALS, 2024, 17 (06)
  • [8] Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography
    Shi, Ximin
    Lin, Xue
    Huo, Li
    Li, Xiang
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (02) : 881 - 884
  • [9] Cardiac fibroblast activation in dilated cardiomyopathy detected by positron emission tomography
    Ximin Shi
    Xue Lin
    Li Huo
    Xiang Li
    Journal of Nuclear Cardiology, 2022, 29 : 881 - 884
  • [10] Relationship Between Cardiac Fibroblast Activation Protein Activity by Positron Emission Tomography and Cardiovascular Disease
    Heckmann, Markus B.
    Reinhardt, Finn
    Finke, Daniel
    Katus, Hugo A.
    Haberkorn, Uwe
    Leuschner, Florian
    Lehmann, Lorenz H.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2020, 13 (09)
12345